摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-Hydroxy-17-methyl-8-oxamorphinan

中文名称
——
中文别名
——
英文名称
3-Hydroxy-17-methyl-8-oxamorphinan
英文别名
rac-7,14α-epoxy-17-methyl-7,14-seco-8-nor-morphinan-3-ol;(1S,9R,10R)-17-methyl-11-oxa-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-trien-4-ol
3-Hydroxy-17-methyl-8-oxamorphinan化学式
CAS
——
化学式
C16H21NO2
mdl
——
分子量
259.348
InChiKey
RFNWFZMJOKXVOP-PMPSAXMXSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.3
  • 重原子数:
    19
  • 可旋转键数:
    0
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.62
  • 拓扑面积:
    32.7
  • 氢给体数:
    1
  • 氢受体数:
    3

反应信息

  • 作为产物:
    描述:
    3-Methoxy-17-methyl-8-oxa-morphinan 在 二苯基膦酸锂 作用下, 以 四氢呋喃 为溶剂, 生成 3-Hydroxy-17-methyl-8-oxamorphinan
    参考文献:
    名称:
    苯并吗啡和8-氧吗啡啉系列的镇痛药和麻醉药拮抗剂。5,
    摘要:
    由相应的5-烯丙基-9α-羟基-2'-甲氧基-2-甲基-6,7-苯并吗啡喃7制备了3-甲氧基-8-氧吗啡喃9。将先前的化合物转化为3-羟基-8 -oxamorphinans 6,一类有效的镇痛药和镇痛剂。在吗啡核的C环中,用氧取代8-CH2可以增强止痛和拮抗活性,而在这些化合物中C-14处的甲基取代氢则可以增强拮抗活性并降低镇痛活性。四氢呋喃并苯并吗啡喃3和3-羟基-8-氧杂异吗啡喃4表现出较低的活性水平。讨论了拮抗剂活性的结构要求。
    DOI:
    10.1021/jm00203a003
点击查看最新优质反应信息

文献信息

  • Analgesics and narcotic antagonists in the benzomorphan and 8-oxamorphinan series. 5
    作者:Yvon Lambert、Jean Paul Daris、Ivo Monkovic、Anthony W. Pircio
    DOI:10.1021/jm00203a003
    日期:1978.5
    transformed to the 3-hydroxy-8-oxamorphinans 6, a class of potent analgesics and analgesic-antagonists. In ring C of the morphinan nucleus substitution of 8-CH2 with oxygen enhanced both analgesic and antagonist activities, while replacement of hydrogen with a methyl group at C-14 in these compounds enhanced antagonist activity and decreased analgesic activity. Tetrahydrofuranobenzomorphans 3 and 3-hydroxy-8-oxaisomorphinans
    由相应的5-烯丙基-9α-羟基-2'-甲氧基-2-甲基-6,7-苯并吗啡喃7制备了3-甲氧基-8-氧吗啡喃9。将先前的化合物转化为3-羟基-8 -oxamorphinans 6,一类有效的镇痛药和镇痛剂。在吗啡核的C环中,用氧取代8-CH2可以增强止痛和拮抗活性,而在这些化合物中C-14处的甲基取代氢则可以增强拮抗活性并降低镇痛活性。四氢呋喃并苯并吗啡喃3和3-羟基-8-氧杂异吗啡喃4表现出较低的活性水平。讨论了拮抗剂活性的结构要求。
查看更多

同类化合物

普罗啡烷 (9R,10R)-15-(环丙基甲基)-10-甲基-11-氧杂-17-氮杂四环[7.5.3.01,10.0(2,7)]十七-2,4,6-三烯-4-醇 3-methoxy-14β-hydroxy-6-oxamorphinan (1S,3aR,5aS,6R,11bR,11cS)-14-(cyclopropylmethyl)-10-methoxy-2,3,3a,4,5,6,7,11c-octahydro-1H-6,11b-(iminoethano)-1,5a-epoxynaphtho[1,2-e]indole (+)-14β-Hydroxy-3-methoxy-17-methyl-6-oxamorphinan N-Propargyl-3-methoxy-14β-methyl-8-oxamorphinan N-Propargyl-3-hydroxy-14β-methyl-8-oxamorphinan NS 28 17-cyclopropylmethyl-7,14α-epoxy-7,14-seco-8-nor-morphinan-3-ol 17-cyclopropylmethyl-7,14α-epoxy-3-methoxy-7,14-seco-8-nor-morphinane (4bR,8R,8aS,9aS,11aS,11bR)-7-(cyclopropylmethyl)-1-hydroxy-11-phenyl-5,6,7,8,9a,11b-hexahydro-8a,11a-ethano-4,8-methano-9,12,14-trioxa-7,11-diazabenzo[a]benzo[4,5]cycloocta[1,2,3-gh]pentalen-10(11H)-one NS22 (1S,5R,13R,14R,17S)-4-methyl-12,19-dioxa-4-azahexacyclo[9.6.1.114,17.01,13.05,17.07,18]nonadeca-7(18),8,10-trien-10-ol KNT-63 (1R,9R,10S,13R)-18-(cyclopropylmethyl)-4-hydroxy-19-oxa-18-azapentacyclo[7.6.3.1^{10,13}.0^{1,10}.0^{2,7}]nonadeca-2(7),3,5-trien-14-one (1S,9R,10R)-17-(cyclopropylmethyl)-11-hydroxy-4-methoxy-12-oxa-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-trien-13-one 17-cyclopropylmethyl-6α,14-epoxy-4,5α-epoxy-3-benzyloxymorphinan Proxorphan tartrate (1S,3aS,5aS,6R,11bR,11cR)-3-benzyl-14-(cyclopropylmethyl)-3a,11-dihydroxy-10-methoxy-1,3,3a,4,5,6,7,11c-octahydro-2H-6,11b-(iminoethano)-1,5a-epoxynaphtho[1,2-e]indol-2-one (4bR,8R,8aS,9aS,11aS,11bR)-7-allyl-11-benzyl-1-hydroxy-5,6,7,8,9a,11b-hexahydro-8a,11a-ethano-4,8-methano-9,12,14-trioxa-7,11-diazabenzo[a]benzo[4,5]cycloocta[1,2,3-gh]pentalen-10(11H)-one (4bR,8R,8aS,9aS,11aS,11bR)-11-benzyl-7-methyl-1-hydroxy-5,6,7,8,9a,11b-hexahydro-8a,11a-ethano-4,8-methano-9,12,14-trioxa-7,11-diazabenzo[a]benzo[4,5]cycloocta[1,2,3-gh]pentalen-10(11H)-one (4bR,8R,8aS,9aS,11aS,11bR)-11-benzyl-1-hydroxy-7-(2-phenethyl)-5,6,7,8,9a,11b-hexahydro-8a,11a-ethano-4,8-methano-9,12,14-trioxa-7,11-diazabenzo[a]benzo[4,5]cycloocta[1,2,3-gh]pentalen-10(11H)-one (4bR,8R,8aS,9aS,11aS,11bR)-11-benzyl-1-hydroxy-7-isobutyl-5,6,7,8,9a,11b-hexahydro-8a,11a-ethano-4,8-methano-9,12,14-trioxa-7,11-diazabenzo[a]benzo[4,5]cycloocta[1,2,3-gh]pentalen-10(11H)-one (4bR,8R,8aS,9aS,11aS,11bR)-7-(cyclopropylmethyl)-1-hydroxy-11-(2-phenethyl)-5,6,7,8,9a,11b-hexahydro-8a,11a-ethano-4,8-methano-9,12,14-trioxa-7,11-diazabenzo[a]benzo[4,5]cycloocta[1,2,3-gh]pentalen-10(11H)-one (1S,5R,13R,14R,17S)-4-(cyclopropylmethyl)-10-methoxy-12,19-dioxa-4-azahexacyclo[9.6.1.114,17.01,13.05,17.07,18]nonadeca-7(18),8,10-triene (4bR,8R,8aS,9aS,11aS,11bR)-11-benzyl-7-(cyclopropylmethyl)-1-hydroxy-5,6,7,8,9a,11b-hexahydro-8a,11a-ethano-4,8-methano-9,12,14-trioxa-7,11-diazabenzo[a]benzo[4,5]cycloocta[1,2,3-gh]pentalen-10(11H)-one 3-methoxy-10α,17-dimethyl-6-oxamorphinan 3-methoxy-17-methyl-10-methylene-6-oxamorphinan rac-7,14α-epoxy-3-methoxy-7,14-seco-8-nor-morphinane (1R,9S,10S)-17-(cyclopropylmethyl)-13-oxa-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-trien-4-ol (1S,9R,10R)-10,17-dimethyl-11-oxa-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-trien-4-ol (1S,9R,10S)-17-(cyclopropylmethyl)-10-methyl-11-oxa-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-trien-4-ol 16-(Cyclopropylmethyl)-10,12-dimethyl-11-oxa-16-azatetracyclo[7.4.3.01,10.02,7]hexadeca-2(7),3,5-trien-4-ol 3-Hydroxy-17-methyl-8-oxamorphinan 12,16-Dimethyl-11-oxa-16-azatetracyclo[7.4.3.01,10.02,7]hexadeca-2(7),3,5-trien-4-ol rac-(6Ξ)-6,14β-epoxy-17-methyl-7,14-seco-8-nor-morphinane (1R,9R,10S)-16-cyclobutyl-10,12-dimethyl-11-oxa-16-azatetracyclo[7.4.3.01,10.02,7]hexadeca-2(7),3,5-trien-4-ol 1-[(1R,9R,10S)-10,16-dimethyl-11-oxa-16-azatetracyclo[7.4.3.01,10.02,7]hexadeca-2,4,6-trien-12-yl]-N,N-dimethylmethanamine;hydrochloride (8S)-6-benzyl-21-(cyclopropylmethyl)-15-hydroxy-11,13,25-trioxa-6,21-diazahexacyclo[12.9.1.12,8.01,9.02,20.018,24]pentacosa-14,16,18(24)-trien-7-one (3S)-5,20-bis(cyclopropylmethyl)-21-oxa-5,20-diazahexacyclo[8.7.3.13,9.01,9.02,6.012,17]henicosa-12(17),13,15-trien-15-ol (3S)-5-benzyl-20-(cyclopropylmethyl)-21-oxa-5,20-diazahexacyclo[8.7.3.13,9.01,9.02,6.012,17]henicosa-12(17),13,15-trien-16-ol [(3R,6S)-14-hydroxy-19-(2-hydroxy-2-methylpropyl)-7-oxa-4,19-diazahexacyclo[7.7.3.13,8.01,8.02,6.011,16]icosa-11(16),12,14-trien-4-yl]-phenylmethanone [(3S)-20-(cyclopropylmethyl)-5-(4,6-dimethyl-1,2-dihydropyrimidin-2-yl)-21-oxa-5,20-diazahexacyclo[8.7.3.13,9.01,9.02,6.012,17]henicosa-12(17),13,15-trien-15-yl] trifluoromethanesulfonate 3-[(3S)-20-(cyclopropylmethyl)-15-methoxy-21-oxa-5,20-diazahexacyclo[8.7.3.13,9.01,9.02,6.012,17]henicosa-12(17),13,15-triene-5-carbonyl]benzonitrile [(3S)-20-(cyclopropylmethyl)-15-hydroxy-21-oxa-5,20-diazahexacyclo[8.7.3.13,9.01,9.02,6.012,17]henicosa-12(17),13,15-trien-5-yl]-(2-fluorophenyl)methanone (1R,3S,9S,10R)-20-(cyclopropylmethyl)-5-(4,6-dimethylpyrimidin-2-yl)-21-oxa-5,20-diazahexacyclo[8.7.3.13,9.01,9.02,6.012,17]henicosa-12(17),13,15-trien-15-ol (1S,3aR,5aS,6R,11bR,11cS)-3-benzyl-14-(cyclopropylmethyl)-10-methoxy-2,3,3a,4,5,6,7,11c-octahydro-1H-6,11b-(iminoethano)-1,5a-epoxynaphtho[1,2-e]indol-11-ol (1S,3aR,5aS,6R,11bR,11cS,12S)-3-benzyl-14-(cyclopropylmethyl)-10-methoxy-1,2,3a,4,5,6,7,11c-octahydro-1H-6,11b-(iminoethano)-1,5a-epoxynaphtho[1,2-e]indol-12-ol (1R,2S,3S,6R,9S,10R)-20-(cyclopropylmethyl)-5-(2-phenylethyl)-21-oxa-5,20-diazahexacyclo[8.7.3.13,9.01,9.02,6.012,17]henicosa-12(17),13,15-trien-15-ol (1S,3aR,5aS,6R,11bR,11cS,12S)-3-benzyl-14-(cyclopropylmethyl)-1,2,3a,4,5,6,7,11c-octahydro-1H-6,11b-(immoethano)-1,5a-epoxynaphtho[1,2-e]indole-10,12-diol